Nuvalent Ownership
| NUVL Stock | USD 92.73 1.56 1.71% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Nuvalent |
Nuvalent Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.49. Nuvalent had not issued any dividends in recent years. Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Nuvalent Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people. To find out more about Nuvalent contact James Porter at 857 357 7000 or learn more at https://www.nuvalent.com.Besides selling stocks to institutional investors, Nuvalent also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nuvalent's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nuvalent's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nuvalent Quarterly Liabilities And Stockholders Equity |
|
Nuvalent Insider Trades History
Roughly 3.0% of Nuvalent are currently held by insiders. Unlike Nuvalent's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nuvalent's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nuvalent's insider trades
Nuvalent Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nuvalent is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuvalent backward and forwards among themselves. Nuvalent's institutional investor refers to the entity that pools money to purchase Nuvalent's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Woodline Partners Lp | 2024-06-30 | 886.1 K | Geode Capital Management, Llc | 2024-06-30 | 782.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 773.3 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 754.1 K | Driehaus Capital Management Llc | 2024-06-30 | 696.6 K | Wellington Management Company Llp | 2024-06-30 | 611.4 K | Fred Alger Management, Llc | 2024-06-30 | 578.1 K | Pictet Asset Manangement Sa | 2024-06-30 | 568.9 K | Silverarc Capital Management, Llc | 2024-06-30 | 465.7 K | Deerfield Management Co | 2024-06-30 | 20 M | Fmr Inc | 2024-09-30 | 9.7 M |
Nuvalent Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvalent insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvalent's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvalent insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nuvalent Outstanding Bonds
Nuvalent issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nuvalent uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nuvalent bonds can be classified according to their maturity, which is the date when Nuvalent has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NUTRIEN LTD 3 Corp BondUS67077MAD02 | View | |
| NUTRIEN LTD 4 Corp BondUS67077MAE84 | View | |
| NTRCN 395 13 MAY 50 Corp BondUS67077MAX65 | View | |
| NTRCN 595 07 NOV 25 Corp BondUS67077MAY49 | View | |
| US67077MAZ14 Corp BondUS67077MAZ14 | View | |
| NUTRIEN LTD Corp BondUS67077MAT53 | View | |
| NUTRIEN LTD Corp BondUS67077MAU27 | View | |
| NUTRIEN LTD 49 Corp BondUS67077MAR97 | View |
Nuvalent Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.49) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.